AccessClosure

About

AccessClosure, Inc. was a medical device company founded in 2002 and based in Mountain View, California. The company specialized in vascular closure devices (VCDs) that addressed complications from manual compression methods after interventional and diagnostic procedures. Its flagship product, the Mynx delivery system, utilized a water-soluble sealant to effectively seal arteriotomies, minimizing tissue trauma and reducing complications. By 2013, the Mynx family of devices had been shipped to over 1,200 catheter labs globally, with cumulative sales exceeding 1.5 million units since 2007. Under the leadership of co-founder Fred Khosravi and CEO Gregory D. Casciaro, AccessClosure achieved significant financial milestones, including annual revenues exceeding $70 million. In 2014, the company was acquired by Cardinal Health, integrating its innovative vascular closure technology into a broader medical device portfolio.